Compositions and methods for diagnosing and treating macular degeneration

US8119348B2 · kind B2 · utility

Assignees

• THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US
• The Trustees of the University of Pennsylvania · US
• Mayo Foundation for Medical Education and Research · US

Inventors

• Anand Swaroop · Gaithersburg, US
• Goncalo Abecasis · Tarrytown, US
• Wei Chen · Singapore, SG
• Dwight Stambolian · Marlton, US
• Albert O. Edwards · Houston, US

Key dates

• Filing date: Jul 12, 2010
• Grant date: Feb 21, 2012
• Expiry date: Jul 12, 2030

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10T436/143333
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The present invention relates generally to biomarkers for macular degeneration. In particular, the present invention provides a plurality of biomarkers for monitoring and diagnosing macular degeneration. The compositions and methods of the present invention find use in diagnostic, therapeutic, research, and drug screening applications.